Pinometostat

N/A

Report date: 2022/11/17 20:00:51
NME

Base Information

Drug NamePinometostat
Drug Alias Name匹诺司他pinometostat匹托司他pinometostatumEPZ-5676 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDOT1 like histone lysine methyltransferase inhibitors
TargetsDOT1 like histone lysine methyltransferase
Therapy Area/IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesLeukemia, Myeloid, Acute +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEpizyme IncCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpizyme IncNational Cancer InstituteCelgene Corp
Active IndicationsN/A
Inactive IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesLeukemia, Myeloid, Acute +[5] 

Other Information

ATC CodeN/A
Related LinksN/A